Omeros (OMER) Long-Term Debt Repayments (2020 - 2023)

Omeros (OMER) reported Long-Term Debt Repayments of $5.0 million for Q4 2023, down 96.02% sequentially from $125.6 million in Q3 2020.

Omeros (OMER) Long-Term Debt Repayments (2020 - 2023) Analysis & Trends

Omeros (OMER) has 2 years of Long-Term Debt Repayments data on file, last reported at $5.0 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Repayments (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	7.64 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Omeros	739.31 Mn	739.31 Mn	9.31 Mn	-

Download Data